Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1351635-67-0

Post Buying Request

1351635-67-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1351635-67-0 Usage

Description

ONO-4059 analog is a derivative of the Bruton’s tyrosine kinase (BTK) inhibitor ONO-4059 .

in vitro

ono-4059 inhibited the tmd-8 cell growth and btk phosphorylation in a concentration-dependent manner. furthermore, the decrease in btk phosphorylation subsequently down-regulated erk phosphorylation. after the combination of ono-4059 with doxorubicin, etoposide, vincristine and dexamethasone, increased apoptosis ratio was observed, 25, 20, 17 and 29%, respectively [1].

in vivo

for the 100-200 mm3 tumour groups, tumour growth inhibition at the final treatment day was 23% in qd, 72.9% in bd and 100% in dose mixed in food, groups respectively. for the 400-450 mm3 tumour groups, no growth inhibition was observed in the qd group and, growth inhibitions of 27.5% in bd and 100% in dose mixed in food were observed. the pk concentration and phosphorylated btk inhibition levels of those animals whose dose was mixed in with food were higher than that of other treatment groups [2].

IC 50

2.2 nm for btk kinase activity

references

[1] tomoko yasuhiro, toshio yoshizawa, joseph tp birkett, and kazuhito kawabata. ono-4059, a novel bruton’s tyrosine kinase (btk) inhibitor: synergistic activity in combination with chemotherapy in a abc-dlbcl cell line. 2013; blood: 122 (21): 5151 - 5151[2] toshio yoshizawa, tomoko yasuhiro, hideyuki honda, and kazuhito kawabata. ono-4059—a potent and selective reversible bruton’s tyrosine kinase (btk) inhibitor: single agent, twice daily (bd) dosing and dosing with food results in sustained, high trough levels of ono-4059, translating into 100% tumour remission in a tmd-8 xenograft model. 2014; blood: 124 (21) 4502 - 4502[3] simon rule, nimish shah, gilles andre salles et al. a phase i study of the oral btk inhibitor ono-4059 in patients with relapsed/refractory b-cell lymphoma. blood. 2013 122 (21): 4397 – 4397.

Check Digit Verification of cas no

The CAS Registry Mumber 1351635-67-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,1,6,3 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1351635-67:
(9*1)+(8*3)+(7*5)+(6*1)+(5*6)+(4*3)+(3*5)+(2*6)+(1*7)=150
150 % 10 = 0
So 1351635-67-0 is a valid CAS Registry Number.

1351635-67-0Upstream product

1351635-67-0Downstream Products

1351635-67-0Relevant articles and documents

PURINONE DERIVATIVE

-

Paragraph 0188; 0189; 0192; 0201; 0202, (2013/04/10)

Compounds represented by general formula (I) (all of the symbols in the formula conform to the definitions in the Description) are compounds that, in addition to having a Btk-selective inhibitory activity, exhibit an excellent metabolic stability and can avoid hepatotoxicity or the like, and as a consequence can provide safe therapeutic agents for diseases in which B cells or mast cells participate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1351635-67-0